-
psnet.ahrq.gov/issue/evaluation-extended-releaselong-acting-opioid-prescribing-risk-evaluation-and-mitigation
March 06, 2019 - July 28, 2010
Prescription opioid analgesics commonly unused after surgery: a systematic
-
psnet.ahrq.gov/issue/underreporting-patient-safety-incidents-reduces-health-cares-ability-quantify-and-accurately
June 08, 2011 - June 7, 2017
Prescription opioid analgesics commonly unused after surgery: a systematic
-
psnet.ahrq.gov/issue/racial-inequality-receipt-medications-opioid-use-disorder
July 20, 2016 - naltrexone , naloxone, or buprenorphine) and limiting prescriptions of high-risk medications (opioid analgesics … August 19, 2020
Assessment of potentially inappropriate prescribing of opioid analgesics
-
psnet.ahrq.gov/issue/outpatient-opioid-prescriptions-children-and-opioid-related-adverse-events
November 30, 2016 - accompanying editorial contextualizes the study findings and offers suggestions, such as relying on less toxic analgesics … August 18, 2010
Assessment of potentially inappropriate prescribing of opioid analgesics
-
psnet.ahrq.gov/issue/public-health-approach-patient-safety-reporting-systems-urgently-needed
May 29, 2013 - June 7, 2017
Prescription opioid analgesics commonly unused after surgery: a systematic
-
psnet.ahrq.gov/issue/national-healthcare-system-action-alliance-advance-patient-safety
November 02, 2016 - outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics … HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics
-
psnet.ahrq.gov/issue/unprotected-broken-promises-georgias-senior-care-industry
May 08, 2013 - HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics … December 8, 2021
Provider bias in prescribing opioid analgesics: a study of electronic
-
psnet.ahrq.gov/issue/ahrq-health-services-research-project-partners-enabling-diagnostic-excellence-r01
August 27, 2008 - HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics … outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics
-
psnet.ahrq.gov/issue/goals-and-priorities-health-care-organizations-improve-safety-using-health-it-revised-report
May 13, 2015 - HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics … outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics
-
psnet.ahrq.gov/issue/2024-national-impact-assessment-centers-medicare-medicaid-services-cms-quality-measures
August 05, 2015 - outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics … HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics
-
psnet.ahrq.gov/issue/testing-and-labeling-medical-devices-safety-magnetic-resonance-mr-environment
January 30, 2008 - outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics … HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics
-
psnet.ahrq.gov/issue/department-defense-dod-patient-safety-program
September 08, 2010 - HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics … outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics
-
psnet.ahrq.gov/issue/professional-conduct-toolkit
September 08, 2010 - HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics … outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics
-
psnet.ahrq.gov/issue/onc-health-it-certification-program-enhanced-oversight-and-accountability
June 29, 2016 - HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics … outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics
-
psnet.ahrq.gov/issue/patient-safety-context-perinatal-neonatal-and-pediatric-care
May 04, 2016 - outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics … HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics
-
psnet.ahrq.gov/issue/hospital-performance-report
June 14, 2006 - outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics … HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics
-
psnet.ahrq.gov/issue/learning-how-learn-compliance-patient-safety-alerts-nhs
March 06, 2005 - July 15, 2020
Provider bias in prescribing opioid analgesics: a study of electronic medical … HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics
-
psnet.ahrq.gov/issue/food-and-drug-administrations-national-drug-code-directory
July 27, 2016 - HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics … outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics
-
psnet.ahrq.gov/issue/physician-owned-specialty-hospitals-ability-manage-medical-emergencies
January 18, 2012 - HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics … outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics
-
psnet.ahrq.gov/issue/medication-management-detailed-use-case
June 29, 2016 - HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics … outpatient measures for reduction of adverse drug events from anticoagulants, diabetes agents, and opioid analgesics